Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.Journal of Medicinal Chemistry|March 12, 2013
Pyrimidoaminotropanes as potent, selective, and efficacious small molecule kinase inhibitors of the mammalian target of rapamycin (mTOR)Anthony A Estrada, Daniel G Shore, Elizabeth Blackwood, et al.Journal of Medicinal Chemistry|March 4, 2011
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activityBrad E Sleebs, Peter E Czabotar, Wayne J Fairbrother, et al.Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.Mbio|September 8, 2016
A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal PeptidaseJ Hiroshi Morisaki, Peter A Smith, Shailesh V Date, et al.Journal of Medicinal Chemistry|April 19, 2011
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidineFrederick Cohen, Philippe Bergeron, Elizabeth Blackwood, et al.Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.Antimicrobial Agents and Chemotherapy|August 15, 2018
Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbAMary Kate Alexander, Anh Miu, Angela Oh, et al.Nature|September 14, 2018
Optimized arylomycins are a new class of Gram-negative antibioticsPeter A Smith, Michael F T Koehler, Hany S Girgis, et al.Journal of Medicinal Chemistry|February 21, 2022
Discovery of Inhibitors of the Lipopolysaccharide Transporter MsbA: From a Screening Hit to Potent Wild-Type Gram-Negative ActivityVishal A Verma, Lan Wang, Sharada S Labadie, et al.Pageof 7